Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
MedStar Health Inc. must face claims it conspired with a revenue-cycle vendor to submit false admissions certifications for patients covered by Medicare ( United States ex rel. Graziosi v. Accretive Health, Inc. , 2017 BL 90282, N.D. Ill., No. 1:13-cv-1194, 3/22/17 ).
Judge Robert M. Dow Jr. of the U.S. District Court for the Northern District of Illinois March 22 refused to dismiss claims brought under the False Claims Act by a former employee of the Columbia, Md.-based hospital company. The employee said MedStar worked with the vendor, Chicago-based Accretive Health Inc., to change recommended patient treatments to increase the number of inpatient admissions at the hospitals.
The employee alleged the changes were made by individuals who weren’t qualified to judge the medical necessity of an inpatient admission for patients and with an eye toward providing a revenue boost for MedStar. Medicare paid more for inpatient admissions than it did for observation stays.
“Accretive for a number of years peddled a practice to top hospital administrators at a significant number of hospitals around the country, convincing them that Accretive could provide to the hospitals what they called a ‘revenue lift’ particularly from the Medicare system,” Brad Pigott of Pigott & Johnson PA in Jackson, Miss., told Bloomberg BNA.
Pigott, who represents the MedStar employee, Cherry Graziosi, said the system was set up so that patients who were determined by physicians to only need observational stays would have to wait while MedStar employees faxed the medical documentation to Accretive and the vendor would second-guess the physician’s recommendations and instead issue a recommendation for inpatient admission, if possible.
“This whole enterprise was designed by Accretive to exploit the tension between the hospital administrators and the hospital’s own physicians over money,” Pigott said.
“Accretive induced hospital administrators to override both the professional integrity of their hospitals’ own doctors and the fiscal integrity of the Medicare system,” he said.
MedStar declined Bloomberg BNA’s requests for comment, citing a policy against commenting on ongoing litigation. Accretive, which changed its name in January to R1 RCM Inc., didn’t respond to Bloomberg BNA’s requests for comment.
In the same order, the court dismissed claims against three other hospital systems, finding the employee hadn’t shown sufficient personal knowledge of arrangements between Accretive and those hospitals.
But Pigott said he expects that the discovery process will lead to his client being able to amend her complaint to add additional claims against those institutions. “We hope to see them again and hope for other hospitals to be held accountable for saying yes to this practice,” he said.
Representatives for the other hospitals didn’t respond to Bloomberg BNA’s requests for comment.
Graziosi is represented by Pigott & Johnson PA in Jackson, Miss. MedStar is represented by Drinker Biddle & Reath LLP in Washington. Accretive is represented by Kirkland & Ellis LLP in Washington. The other hospital systems were represented by Akin Gump Strauss Hauer & Feld LLP in Washington, Foley & Lardner LLP in Washington and Epstein Becker & Green PC in Washington.
To contact the reporter on this story: Matthew Loughran in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Peyton M. Sturges at PSturges@bna.com
The court's opinion is at http://src.bna.com/ni9.
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)